Devi Ramanan Email & Phone Number

California, United States

Oakland, Ca, Us

Democratizing great healthcare for all with Machine Learning and Data Science. Grateful to be on this mission-driven team. We are hiring! If you also believe in our 4 core values, please ping us!

Seattle, Wa, Us

Machine Learning & Data Science

Washington, District Of Columbia, Us

Predicting Alzheimer's Disease using AI/ML.

Austin, Texas, Us

data.world (a) strives to build the most meaningful, collaborative and abundant data resource in the world in order to maximize data’s societal problem-solving utility, (b) advocates publicly for improving the adoption, usability, and proliferation of open data and linked data, and (c) serves as an accessible historical repository of the world’s data. https://data.world/deviramanan2016

New York, Ny, Us

Genomics, artificial intelligence, and computational biology to address the limitations of traditional testing

Scottsdale, Arizona, Us

NeoLight is a med-tech startup that develops empathy-driven and best-in-class technologies for preventable conditions occurring in newborn infants.

Nashville, Tennessee, Us

Clover is a physician enablement company focused on seniors who have historically lacked access to affordable, high-quality healthcare. We aim to provide great care, in a sustainable way, by having a business model built around improving medical outcomes while lowering avoidable costs. We do this while taking a holistic approach to understanding the health needs and social risk factors of those under our care. This strategy is underpinned by our proprietary software platform, the Clover Assistant, which is designed to aggregate patient data from across the health ecosystem to support clinical decision-making by presenting physicians and other providers with real-time, personalized recommendations at the point of care.

Dublin 2, Ie

Built & grew (P&L responsibility) Accenture West Market Unit’s Health practice (Providers, Payers, Biotech/Pharma, Research, etc) with machine learning & data science. Grateful to be part of the amazing Team that contributed to rolling out the State of CA Covid Vaccines in early 2021.

My awesome Co-Founder and I worked together with our scientific advisors on a disruptive data science concept to improve characterizations of patients, diagnosis, risk, and subtype stratification in chronic diseases (asthma, diabetes, etc).

Fast Company's Most Innovative Companies - 2014, 2015Technology Pioneer WEF - 2015"Machine Intelligence Health" book, http://bit.ly/MIforHealthcare Built the Global Product Collaborations Program where our mission was to enable the best Key Opinion Leaders/Thought Leaders in Academia, Foundations, Non-Profits & Think-Tanks to use our software & Python SDK to solve the world's problems. We had active Collabs spanning several verticals: Financial Services, Health, Public Sector. i.e. Gates, IIF, NIH, Stanford, UCSF, Columbia, Mt. Sinai, etc. 100+ top pubs in Nature, Science, Cell: https://www.ayasdi.com/knowledge-center/?type=global-community-researchBlogs - https://medium.com/@devi_ramananhttps://towardsdatascience.com/why-is-ayasdi-topological-data-analyses-the-source-of-so-many-breakthroughs-in-science-5fdc6b8a6f57UBIOPRED/NHS - Asthma:https://towardsdatascience.com/artificial-intelligence-aids-medical-researchers-in-uncovering-genetic-signature-for-severe-asthma-f8125b926915Genomics:https://towardsdatascience.com/the-shape-of-the-genome-going-beyond-the-double-helix-with-topological-data-analysis-29021b860ebcStanford - Predicting Disease Recovery:https://towardsdatascience.com/understanding-the-disease-cycle-groundbreaking-research-from-stanford-using-tda-81cfb595d605Mt. Sinai - Diabetes:https://towardsdatascience.com/identification-of-type-2-diabetes-subgroups-through-topological-data-analysis-of-patient-similarity-91838f2ccf74UCSF - TBI:https://towardsdatascience.com/ucsf-scientists-use-artificial-intelligence-to-uncover-hallmarks-of-traumatic-brain-injury-a672ae75704aStowers - Protein Structure:https://medium.com/@devi_ramanan/stowers-scientists-use-artificial-intelligence-to-uncover-new-relationships-and-organizational-2c048ad94251Syrian Polio Vaccination:https://medium.com/@devi_ramanan/why-collaborations-matter-to-ayasdi-756036a259eeMacroeconomics:https://www.ayasdi.com/student-finds-shape-meaning-four-decades-economic-data/

New York, Us

Introduced company to 3 major West Coast customers, leading to multi-million dollar deals. Context Matters is leading the charge to a truly data-driven, drug-development process. Their software application gives customers instant and constant access to data and analytics in an easy-to-use and powerful web-based interface. Data is curated, standardized, and visualized, allowing customers to track and comprehend the increasingly complex global reimbursement environment. This gives customers a strategic advantage in their decision-making, so they can focus on the key drivers of success. Acquired by Decision Resources Group

San Francisco, Ca, Us

Managed & completed various initiatives, including but not limited to: product launches (Program Lead of Commercial Launch, a large cross functional team), pricing/access, reimbursement (collaboration with external partner), scientific presence at congresses (submitted abstracts & created poster for ESMO 2013), product technical brochures, customer success/client services processes/FAQs (interim Customer Success Lead), advocacy outreach campaigns, defined clinical use cases, created sales pitch decks, key competitive analyses, health economics outcomes research/payer related activities, launch work-planning, technical/validation whitepapers, etc. Responsible for hiring, training, coaching, developing & empowering talentJ. Hagenkord et al, A multi-use low-cost germline genetic test for over 211 genes, including several genes affecting cancer diagnosis and treatment, ESMO 2013 (drafted/submitted abstract & poster)

Menlo Park, Ca, Us

Product Head for 2 key Product (chemistry) Launches. Led cross-functional teams to define requirements/workflows for R&D, train field, partners & customers. Also managed post launch workflows. Targeted Sequencing Application Lead: SNP Validation & Detection, Splice Variants, cDNA, Haplotying (HLA), Rare Variants, etc. Defined detailed use cases and end-to-end workflow requirements from Sample Prep to Bioinformatics analyses. Launched a key Nature publication with R&D partners, including detailed Computational Biology & Sample Prep (FAQs, slides, etc for sales/customers). Led key product initiatives/collaborations with partners and customers alike, including defining requirements & launching new kits & controls. Led & implemented an online community for partners/collaborators to share recent R&D protocols, techniques & ideas on an online discussion forum.

South San Francisco, California, Us

Worked on 4 large product launches: Lucentis (AMD), Avastin (GBM & RCC), Vismodegib (aBCC)Commercialization/Operations: Health Economics & Outcomes Research (HEOR), Comparative Effectiveness Research (CER)In cross-functional teams optimized development decisions & commercialization of molecules by providing economic assessments (pharmacoeconomic modeling) & related evidence throughout the life cycle of molecules. This information complements data on efficacy/safety to demonstrate the evidence-based value proposition for molecules in the context of competitive environments. Worked on Avastin GBM + RCC launches. Most recently worked on niche skin cancer launch (advanced basal cell carcinoma), doing primary market research, with publications at scientific congresses.Product Development: Strategic Decision AnalysisKey Core Team Rep on 7 Immunology Development & Post Launch molecules (Lucentis, Xolair, THA (Curis) & 4 pipeline teams). For 2 large Business Development deals, developed unique valuation methodology & models. Developed novel financial forecasting valuation models (DCF/NPV) with Monte Carlo simulations. Worked on Lucentis (ophthalmology) launch. Drove Strategic Initiatives & Special Projects with Senior Mgmt (i.e. Life Cycle Planning, Long Range Planning, Device Strategy, etc.)

South San Francisco, California, Us

M. Walker, L. Schwartzberg, D. Chen, D. Ramanan, A. Houts, C. Reyes, Treatment Patterns and Clinical Characteristics of Patients with Advanced Basal Cell Carcinoma (aBCC) in the Community Oncology Setting, Journal of Cancer Therapy 2013M. Walker, L. Schwartzberg, D. Chen, D. Ramanan, Treatment Patterns and Clinical Characteristics of Patients with Advanced Basal Cell Carcinoma (aBCC) in the Community Oncology Setting, American Association of Dermatology 2012S. Satram-Hoang, D. Ramanan, L. Lee, S. Yu, C. Reyes, E. McKenna, Comparative effectiveness of treatment options in elderly patients with colon cancer receiving adjuvant chemotherapy, ASCO Gastrointestinal (GI) Cancers 2012S. Satram-Hoang, D. Ramanan, L. Lee, S. Yu, C. Reyes, E. McKenna, Comparative effectiveness of chemotherapy in elderly patients with metastatic colorectal cancer., ASCO GI 2012A.D. Joshi, M. Forsyth, D. Fryefield, W. Lopez, D.M. Chen, D.D. Ramanan, Patient Characteristics and Treatment Patterns in Advanced Basal Cell Carcinoma (aBCC) in Oncology Community Setting, European Society of Medical Oncology (ESMO) 2011S.D. Byfield, D.M. Chen, D.D. Ramanan, Cost and Patterns of Care among Patients with Advanced Non-Melanoma Skin Cancer, American Society of Clinical Oncology (ASCO) 2011A.D. Joshi, M. Forsyth, D. Fryefield, W. Lopez, D.M. Chen, D.D. Ramanan, Demographic and Treatment Characteristics for Advanced Basal Cell Carcinoma (aBCC) in an Oncology Outpatient Setting, ASCO 2011

Palo Alto, Ca, Us

Zurich, Ch

Summer Associate, Institutional Investor (top) Ranked Biotech Team (Analysts: Meirav Chovav, Derik De Bruin)Evaluated & initiated coverage of 2 life sciences tools companies, using extensive financial modeling & completing detailed 40-page initiation reports. Presented results to Global Product Manager, Head of Global Equity Research & other C-level executives in the firm. Interviewed C-level executives of the 2 companies & discussed growth strategies/issues to develop valuation & research report

Dublin 2, Ie

Strategic Global Technology Management ConsultingProgressed quickly from an individual contributor to managing cross-functional international teams on 8 different International/US-based clients. Worked in varying fields of electronics & high tech, communications, resources/energy, and health. Always received highest performance ratings internally & from clients. Always finished under budget & on time. Frequently presented strategic deliverables to several stakeholders, including client senior executives. Programming skills include C, C++, Java, Perl, UNIX, SQL, Visual Basic, XML, SAP Basis/ABAP, HTML, Interface Architecture, and Novient.

Master Of Business Administration (Mba), Double Major: Health & Financial Engineering (Minor: Market Research)

Began Phd (Full University Fellowship), Left With Ms, Brain And Cognitive Science (Aka Biochemistry/Biophysics)

Education record

Bachelor Of Science (Bs), Majors: Electrical Engineering/Physical Chemistry; Minor: Biology

Education record